Glenmark Pharmaceuticals Ltd
BSE:532296
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Glenmark Pharmaceuticals Ltd
BSE:532296
|
IN |
|
M
|
Metro Inc
XBER:62M
|
CA |
|
Infinity Lithium Corporation Ltd
ASX:INF
|
AU |
|
N
|
Norfolk Southern Corp
F:NFS
|
US |
|
S
|
Sasol Ltd
JSE:SOL
|
ZA |
|
N
|
Nippon Telegraph and Telephone Corp
F:NTT
|
JP |
|
W
|
Westpac Banking Corp
F:WBCC
|
AU |
|
Treasury Wine Estates Ltd
ASX:TWE
|
AU |
|
Ocado Group PLC
F:0OC1
|
UK |
|
Trillion Energy International Inc
F:Z620
|
CA |
|
S
|
Sula Vineyards Ltd
BSE:543711
|
IN |
|
Evolution AB (publ)
OTC:EVGGF
|
SE |
|
F
|
Federal Home Loan Mortgage Corp
OTC:FMCC
|
US |
|
Kardex Holding AG
F:KAX2
|
CH |
|
S
|
Salesforce Inc
XETRA:FOO
|
US |
|
Triboo SpA
MIL:TB
|
IT |
|
Mediaalpha Inc
NYSE:MAX
|
US |
|
U
|
UPM-Kymmene Oyj
DUS:RPL
|
FI |
|
Whirlpool of India Ltd
NSE:WHIRLPOOL
|
IN |
|
N
|
Norfolk Southern Corp
XMUN:NFS
|
US |
|
SmileDirectClub Inc
F:0WF
|
US |
|
Sienna Resources Inc
XTSX:SIEN
|
CA |
|
Cryoport Inc
F:CKX
|
US |
Wall St Price Targets
GLENMARK Price Targets Summary
Glenmark Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for GLENMARK is 2 438.9318 INR with a low forecast of 1 517.1468 INR and a high forecast of 2 890.8014 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GLENMARK's stock price target?
Price Target
2 438.9318
INR
According to Wall Street analysts, the average 1-year price target for GLENMARK is 2 438.9318 INR with a low forecast of 1 517.1468 INR and a high forecast of 2 890.8014 INR.
What is the Revenue forecast for Glenmark Pharmaceuticals Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 4 years is 12%.
What is the Gross Profit forecast for Glenmark Pharmaceuticals Ltd?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 4 years is 15%.
What is the Operating Income forecast for Glenmark Pharmaceuticals Ltd?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 4 years is 20%.
What is the Pre-Tax Income forecast for Glenmark Pharmaceuticals Ltd?
Projected CAGR
38%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 38%.
What is the Net Income forecast for Glenmark Pharmaceuticals Ltd?
Projected CAGR
32%
Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 4 years is 32%.
